PACK-CXL vs. antimicrobial therapy for bacterial, fungal, and mixed infectious keratitis: a prospective randomized phase 3 trial.

Farhad HafeziMohammed HosnyRohit ShettyBoris KnyazerShihao ChenQinmei WangHassan HashemiEmilio A Torres-Nettonull null

Published in: Eye and vision (London, England) (2022)

PACK-CXL may be an alternative to antimicrobial drugs for first-line and standalone treatment of early to moderate infectious keratitis of bacterial or fungal origin. Trial registration This trial is registered at ClinicalTrials.gov, trial registration number: NCT02717871.

Keyphrases

phase iii
study protocol
phase ii
clinical trial
staphylococcus aureus
randomized controlled trial
open label
high intensity
combination therapy
replacement therapy
placebo controlled